Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Fungal disease in humans
  • Track 1-2Pathogenesis and Virulence
  • Track 1-3Antifungal susceptibility and resistance
  • Track 1-4Zoonotic infections
  • Track 1-5Fungal pathogens
  • Track 1-6Laboratory Diagnosis of Fungal Infections
  • Track 1-7Epidemiology and public health mycology
  • Track 2-1Mitochondrial Inheritance
  • Track 2-2Relevant Features of Fungal Life Cycles
  • Track 2-3Recombination Analysis
  • Track 2-4Genome Interactions
  • Track 2-5Formal Genetic Analysis – Information from Tetrads
  • Track 2-6Systematics, Phylogeny, and Evolution
  • Track 2-7Analysis of Whole Genomes
  • Track 3-1Eco-physiology
  • Track 3-2Bioremediation and biodegradation
  • Track 3-3Nutrient cycling, decomposition and carbon allocation
  • Track 3-4Population dynamics, adaptation and evolution
  • Track 3-5Intra- and inter-specific mycelial interactions
  • Track 3-6fungal interactions
  • Track 4-1Fungi as cell factories
  • Track 4-2Production of recombinant polypeptides
  • Track 4-3Genetic engineering of filamentous fungi
  • Track 4-4Synthetic biology
  • Track 5-1Classification
  • Track 5-2Systematic
  • Track 5-3Molecular phylogeny
  • Track 5-4The genomic revolution
  • Track 6-1Candida matrix and biofilm drug resistance
  • Track 6-2Biofilm extracellular matrix
  • Track 6-3Clinical Significance of Fungal Biofilms
  • Track 6-4Candida albicans
  • Track 6-5Candida dubliniensis
  • Track 7-1Reishi (Ganoderma Lucidum)
  • Track 7-2Chaga (Inonotus Obliquus)
  • Track 7-3Turkey Tail (Trametes Versicolor)
  • Track 7-4Cordyceps sinensis
  • Track 7-5Psilocybin Mushrooms
  • Track 7-6Medicines from Fungi: Penicillin, Lovastatin and Cyclosporine
  • Track 9-1MDR Between Azoles and Amphotericin B
  • Track 9-2Fungisome Gel
  • Track 9-3Role of azoles in the treatment of invasive mycoses
  • Track 9-4visceral mycoses and their treatment
  • Track 14-1Current trends in antifungal chemotherapy
  • Track 14-2Current Trends in Diagnosis and Treatment of Onychomycosis
  • Track 14-3Filamentous fungi as cell factories for heterologous protein production
  • Track 14-4Green approach for nanoparticle biosynthesis by fungi
  • Track 14-5Fungi for Bioremediation of Oil-Contaminated Soil
  • Track 14-6Fungi recycle batteries